» Articles » PMID: 38102691

HDAC5-mediated Exosomal Maspin and MiR-151a-3p As Biomarkers for Enhancing Radiation Treatment Sensitivity in Hepatocellular Carcinoma

Abstract

Background: Tumor-derived exosomes are critical elements of the cell-cell communication response to various stimuli. This study aims to reveal that the histone deacetylase 5 (HDAC5) and p53 interaction upon radiation in hepatocellular carcinoma intricately regulates the secretion and composition of exosomes.

Methods: We observed that HDAC5 and p53 expression were significantly increased by 2 Gy and 4 Gy radiation exposure in HCC. Normal- and radiation-derived exosomes released by HepG2 were purified to investigate the exosomal components.

Results: We found that in the radiation-derived exosome, exosomal Maspin was notably increased. Maspin is known as an anti-angiogenic gene. The expression of Maspin was regulated at the cellular level by HDAC5, and it was elaborately regulated and released in the exosome. Radiation-derived exosome treatment caused significant inhibition of angiogenesis in HUVECs and mouse aortic tissues. Meanwhile, we confirmed that miR-151a-3p was significantly reduced in the radiation-derived exosome through exosomal miRNA sequencing, and three HCC-specific exosomal miRNAs were also decreased. In particular, miR-151a-3p induced an anti-apoptotic response by inhibiting p53, and it was shown to induce EMT and promote tumor growth by regulating p53-related tumor progression genes. In the HCC xenograft model, radiation-induced exosome injection significantly reduced angiogenesis and tumor size.

Conclusions: Our present findings demonstrated HDAC5 is a vital gene of the p53-mediated release of exosomes resulting in tumor suppression through anti-cancer exosomal components in response to radiation. Finally, we highlight the important role of exosomal Maspin and mi-151a-3p as a biomarker in enhancing radiation treatment sensitivity. Therapeutic potential of HDAC5 through p53-mediated exosome modulation in radiation treatment of hepatocellular carcinoma.

Citing Articles

The paradoxical role of SERPINB5 in gastrointestinal cancers: oncogene or tumor suppressor?.

Zeng S, Zhang J, Jiang W, Zeng C Mol Biol Rep. 2025; 52(1):188.

PMID: 39899168 DOI: 10.1007/s11033-025-10293-w.


Nonylphenol promotes epithelial-mesenchymal transition in colorectal cancer cells by upregulating miR-151a-3p.

Wang B, Zhang N, Dai L, Zhang Y, Yin S, Yang X Discov Oncol. 2025; 16(1):63.

PMID: 39832042 PMC: 11747012. DOI: 10.1007/s12672-025-01805-y.


Role of extracellular vesicle-associated proteins in the progression, diagnosis, and treatment of hepatocellular carcinoma.

Liu Y, Jiang S, Zhang J, Zheng H, Zhang L, Zhao H Cell Biosci. 2024; 14(1):113.

PMID: 39227992 PMC: 11373138. DOI: 10.1186/s13578-024-01294-6.

References
1.
Chen R, Xu X, Tao Y, Qian Z, Yu Y . Exosomes in hepatocellular carcinoma: a new horizon. Cell Commun Signal. 2019; 17(1):1. PMC: 6323788. DOI: 10.1186/s12964-018-0315-1. View

2.
Butt Z, Parikh N, Beaumont J, Rosenbloom S, Syrjala K, Abernethy A . Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI). Cancer. 2012; 118(23):5997-6004. PMC: 3424375. DOI: 10.1002/cncr.27588. View

3.
Zhao L, Liu W, Xiao J, Cao B . The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance. Cancer Lett. 2014; 356(2 Pt B):339-46. DOI: 10.1016/j.canlet.2014.10.027. View

4.
Mashouri L, Yousefi H, Aref A, Ahadi A, Molaei F, Alahari S . Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019; 18(1):75. PMC: 6444571. DOI: 10.1186/s12943-019-0991-5. View

5.
Lin X, Fang J, Yang X, Zhang C, Yuan Y, Zheng L . Hepatocellular Carcinoma Cell-Secreted Exosomal MicroRNA-210 Promotes Angiogenesis In Vitro and In Vivo. Mol Ther Nucleic Acids. 2018; 11:243-252. PMC: 5992447. DOI: 10.1016/j.omtn.2018.02.014. View